tazarotene
RxNorm concept 83947, ingredient (in).
- RxCUI
- 83947
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/83947 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Tazorac (BN, has tradename)
- Fabior (BN, has tradename)
- Duobrii (BN, has tradename)
- Arazlo (BN, has tradename)
- Trilitas (BN, has tradename)
- tazarotene 0.0005 MG/MG (SCDC, ingredient of)
- tazarotene 0.001 MG/MG (SCDC, ingredient of)
- tazarotene 1 MG/ML (SCDC, ingredient of)
- tazarotene 0.5 MG/ML (SCDC, ingredient of)
- tazarotene Topical Cream (SCDF, ingredient of)
- tazarotene Topical Gel (SCDF, ingredient of)
- tazarotene Topical Product (SCDG, ingredient of)
- tazarotene Topical Foam (SCDF, ingredient of)
- tazarotene 0.45 MG/ML (SCDC, ingredient of)
- halobetasol / tazarotene Topical Product (SCDG, ingredient of)
- halobetasol / tazarotene Topical Lotion (SCDF, ingredient of)
- tazarotene Topical Lotion (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 83947 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/83947 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 83947. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.